Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

NCT04968184 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

652

Enrollment

INDUSTRY

Sponsor class

Stopped Interim futility analysis showed primary endpoint not achieved

Conditions

Chronic Kidney Diseases

Interventions

DRUG: Placebo
DRUG: KBP-5074

Sponsor

KBP Biosciences